Acacia Subsidiary Acquires 1,900 Medical Patents and Applications
Acacia Research Corporation (NASDAQ: ACTG) announced today that a
subsidiary has acquired 7 patent portfolios with over 1,900 patents and
applications relating to stent grafts, vascular grafts, bypass grafts,
graft retrieval technology, graft manufacturing technology, vena cava
filter technology, and filter retrieval technology from a leading global
medical device company.
“As Acacia's licensing success in the medical technology sector grows,
we are pleased to announce that a leading global medical device company
has chosen Acacia as their trusted partner for the licensing of their
patented technologies,” commented Paul Ryan, Acacia CEO.
“This transaction is one of our largest partnerships to date and is a
validation of our